Endocrine Pathology — MCQs
On this page
A 70-year-old male presented to the OPD with fatigue. His fasting blood glucose was 110 mg/dL, postprandial glucose was 180 mg/dL, and HbA1c was 6.1%. What is your diagnosis?
Amyloid stroma is seen in which type of thyroid carcinoma?
A 20-year-old woman and her twin sister both experience increasing diplopia. Their conditions develop within 3 years of each other. On physical examination, they have exophthalmos and weak extraocular muscle movement. The thyroid gland is diffusely enlarged but painless in each sister, and there is no lymphadenopathy in either woman. Which of the following serum laboratory findings is most likely to be reported in these sisters?
In the thyroid gland, the colloid material is predominantly composed of which of the following?
Amyloidosis is most commonly seen in which type of Diabetes Mellitus?
A 38-year-old woman undergoes a subtotal thyroidectomy. The biopsy specimen contains psammoma bodies and prominent papillae of epithelium with a fibrovascular core. The nuclear region of the cells shows groove formation, optical clearing, eosinophilic inclusions, and overlapping of nuclei. Which of the following is the most likely diagnosis?
Which type of diabetes is associated with HLA?
Acidophil stem cell tumors present with all of the following features except?
Which of the following describes humoral hypercalcemia of malignancy (HHM)?
All of the following are histological features of follicular carcinoma, except?
Endocrine Pathology Indian Medical PG Practice Questions and MCQs
Question 21: A 70-year-old male presented to the OPD with fatigue. His fasting blood glucose was 110 mg/dL, postprandial glucose was 180 mg/dL, and HbA1c was 6.1%. What is your diagnosis?
- A. Prediabetes (Correct Answer)
- B. Stress-induced hyperglycemia
- C. Normal glucose tolerance
- D. Diabetes mellitus
Explanation: **Explanation:** The diagnosis of **Prediabetes** is based on the ADA (American Diabetes Association) criteria, which define a state where blood glucose levels are higher than normal but do not yet meet the threshold for Diabetes Mellitus [1]. **1. Why Prediabetes is correct:** The patient’s values fall precisely within the prediabetic ranges [1]: * **Impaired Fasting Glucose (IFG):** 100–125 mg/dL (Patient: 110 mg/dL). * **Impaired Glucose Tolerance (IGT):** 2-hour postprandial (or OGTT) 140–199 mg/dL (Patient: 180 mg/dL). * **HbA1c:** 5.7% to 6.4% (Patient: 6.1%). Since all three parameters align with these ranges, prediabetes is the definitive diagnosis. **2. Why other options are incorrect:** * **Normal Glucose Tolerance:** Normal values are Fasting <100 mg/dL, 2-hr PP <140 mg/dL, and HbA1c <5.7%. This patient exceeds all these limits. * **Diabetes Mellitus:** Requires Fasting ≥126 mg/dL, 2-hr PP ≥200 mg/dL, or HbA1c ≥6.5%. The patient’s values are below these cut-offs [1]. * **Stress-induced Hyperglycemia:** This is a transient rise in glucose due to acute illness (e.g., sepsis, MI). The patient presents with chronic fatigue and an elevated HbA1c, which reflects average glycemia over 3 months, ruling out an acute stress response. **High-Yield Clinical Pearls for NEET-PG:** * **HbA1c Limitations:** It can be falsely low in conditions with high red cell turnover (e.g., Hemolytic anemia, Pregnancy) and falsely high in Iron deficiency anemia. * **Screening:** In asymptomatic adults, screening for prediabetes/diabetes should begin at age 35 (revised from 45). * **Conversion:** Prediabetes carries a high risk of progression to Type 2 DM (approx. 5-10% per year) and is already associated with an increased risk of cardiovascular disease [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1109-1111.
Question 22: Amyloid stroma is seen in which type of thyroid carcinoma?
- A. Papillary carcinoma
- B. Medullary carcinoma (Correct Answer)
- C. Anaplastic carcinoma
- D. Follicular carcinoma
Explanation: **Explanation:** **Medullary Thyroid Carcinoma (MTC)** is the correct answer because it originates from the **Parafollicular C-cells** [2], which are neuroendocrine cells that secrete **Calcitonin** [1]. The characteristic amyloid stroma is formed by the deposition of pro-calcitonin molecules that undergo misfolding into soluble fibrillar proteins. On histology, these appear as acellular, eosinophilic areas that show **apple-green birefringence** under polarized light when stained with **Congo Red** [3]. **Analysis of Incorrect Options:** * **Papillary Carcinoma:** The most common thyroid cancer [5]. It is characterized by **Psammoma bodies** (laminated calcifications), Orphan Annie eye nuclei, and nuclear grooves [5], but it does *not* contain amyloid. * **Follicular Carcinoma:** Characterized by capsular and vascular invasion [3]. It produces thyroglobulin, not calcitonin, and lacks amyloid stroma. * **Anaplastic Carcinoma:** A highly aggressive, undifferentiated tumor [4]. Histology shows pleomorphic giant cells or spindle cells with frequent mitoses [4], but amyloid is not a feature. **High-Yield Clinical Pearls for NEET-PG:** * **Origin:** Derived from the ultimobranchial body (C-cells) [2]. * **Genetics:** Associated with **RET proto-oncogene** mutations. It is a key component of **MEN 2A and 2B** syndromes [1]. * **Biomarker:** Serum **Calcitonin** is used for diagnosis and monitoring recurrence; Carcinoembryonic Antigen (CEA) is also often elevated [1]. * **Staining:** Positive for neuroendocrine markers like Chromogranin and Synaptophysin [3]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1102-1103. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 428-429. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 430-431. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1101-1102. [5] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 429-430.
Question 23: A 20-year-old woman and her twin sister both experience increasing diplopia. Their conditions develop within 3 years of each other. On physical examination, they have exophthalmos and weak extraocular muscle movement. The thyroid gland is diffusely enlarged but painless in each sister, and there is no lymphadenopathy in either woman. Which of the following serum laboratory findings is most likely to be reported in these sisters?
- A. Decreased free thyroxine level
- B. Decreased thyroid-stimulating hormone level (Correct Answer)
- C. High titer thyroid peroxidase autoantibodies
- D. Increased thyrotropin-releasing hormone level
Explanation: ### **Explanation** The clinical presentation of **bilateral exophthalmos**, **diplopia** (due to infiltrative ophthalmopathy), and a **painless, diffusely enlarged thyroid** in young women is classic for **Graves’ Disease** [1]. The fact that it occurs in twins highlights the strong genetic predisposition associated with HLA-DR3 and HLA-B8. **1. Why the Correct Answer is Right:** Graves’ disease is caused by **Type II hypersensitivity**, where B-cells produce **Thyroid Stimulating Immunoglobulins (TSI)**. These autoantibodies bind to and activate the TSH receptors on thyroid follicular cells, mimicking the action of TSH. This leads to autonomous, excessive production of T3 and T4. Through the **negative feedback mechanism**, these high levels of circulating thyroid hormones suppress the anterior pituitary, resulting in a **decreased (often undetectable) serum TSH level** [1]. **2. Why Other Options are Wrong:** * **Option A (Decreased free thyroxine):** In Graves’ disease, free T4 (thyroxine) and T3 are characteristically **increased**, causing clinical hyperthyroidism [1]. * **Option C (High titer TPO antibodies):** While TPO antibodies can be present in Graves’, they are the hallmark of **Hashimoto’s Thyroiditis** [3]. Hashimoto’s typically presents with hypothyroidism and lacks the specific infiltrative ophthalmopathy (exophthalmos) seen here. * **Option D (Increased TRH):** High levels of T3 and T4 suppress the hypothalamus, leading to **decreased** Thyrotropin-Releasing Hormone (TRH) levels. **3. NEET-PG High-Yield Pearls:** * **Triad of Graves:** Hyperthyroidism (diffuse goiter), Ophthalmopathy (exophthalmos), and Dermopathy (Pretibial myxedema). * **Pathogenesis of Exophthalmos:** T-cells react against TSH receptors behind the orbit, causing cytokine release, fibroblast proliferation, and accumulation of **glycosaminoglycans (GAGs)** [2], leading to muscle swelling and edema. * **Histology:** Look for **scalloping of colloid** (clear vacuoles at the edge of the colloid) and tall, crowded follicular epithelial cells [2]. * **Most Specific Antibody:** Thyroid Stimulating Immunoglobulin (TSI). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1087-1088. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, p. 1093. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1090-1091.
Question 24: In the thyroid gland, the colloid material is predominantly composed of which of the following?
- A. Thyroxine
- B. Thyroglobulin (Correct Answer)
- C. Monoiodotyrosine
- D. Diiodotyrosine
Explanation: **Explanation:** **1. Why Thyroglobulin is Correct:** The thyroid follicle is the functional unit of the thyroid gland. The central lumen of these follicles is filled with **colloid**, a viscous fluid. The primary constituent of this colloid is **Thyroglobulin (Tg)** [1], a large dimeric glycoprotein synthesized by the follicular epithelial cells. Thyroglobulin acts as a scaffold for thyroid hormone synthesis and a storage form of iodine. It contains tyrosine residues that undergo iodination to eventually form T3 and T4. **2. Why Other Options are Incorrect:** * **Thyroxine (T4):** While T4 is the major hormone produced by the thyroid, it is stored *within* the thyroglobulin molecule in the colloid. It is not the "predominant material" itself but a product cleaved from Tg before secretion into the blood. * **Monoiodotyrosine (MIT) & Diiodotyrosine (DIT):** These are intermediate iodinated tyrosine residues found attached to the thyroglobulin backbone. They are precursors to T3 and T4 and do not exist independently as the bulk of the colloid. **3. High-Yield Clinical Pearls for NEET-PG:** * **PAS Staining:** Thyroid colloid is strongly **PAS (Periodic Acid-Schiff) positive** [1] due to the high carbohydrate content of thyroglobulin. * **Scalloping:** In hyperactive states (like Graves' disease), the colloid shows "peripheral scalloping" or "moth-eaten" appearance due to rapid endocytosis of thyroglobulin by follicular cells. * **Tumor Marker:** Serum thyroglobulin is used as a tumor marker to monitor the recurrence of **Papillary and Follicular thyroid carcinomas** after total thyroidectomy. * **Site of Action:** The coupling of MIT and DIT occurs at the apical surface/colloid interface, catalyzed by **Thyroid Peroxidase (TPO)**. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1085-1086.
Question 25: Amyloidosis is most commonly seen in which type of Diabetes Mellitus?
- A. Maturity onset diabetes mellitus
- B. Type I diabetes mellitus
- C. Type II diabetes mellitus (Correct Answer)
- D. Hypertension
Explanation: **Explanation:** The correct answer is **Type II Diabetes Mellitus (T2DM)**. The hallmark pathological finding in the pancreatic islets of patients with T2DM is the deposition of **Amyloid**. **1. Why Type II Diabetes Mellitus is correct:** In T2DM, there is a state of insulin resistance leading to the hypersecretion of insulin by pancreatic beta cells. Insulin is co-secreted with a regulatory peptide called **Amylin** (also known as **Islet Amyloid Polypeptide or IAPP**). In chronic T2DM, this excessive production leads to the misfolding and aggregation of IAPP into insoluble amyloid fibrils [1]. These deposits are found in the extracellular space of the Islets of Langerhans, eventually leading to beta-cell replacement and atrophy. **2. Why other options are incorrect:** * **Type I Diabetes Mellitus:** This is an autoimmune condition characterized by the destruction of beta cells. The typical pathology shows **Insulitis** (lymphocytic infiltration) rather than amyloidosis [1]. * **Maturity Onset Diabetes of the Young (MODY):** This refers to a group of monogenic disorders resulting in beta-cell dysfunction. It does not typically involve the amyloid deposition seen in the polygenic T2DM. * **Hypertension:** While often comorbid with T2DM (Metabolic Syndrome), hypertension itself causes **Hyaline Arteriolosclerosis** in the kidneys and other organs, not pancreatic amyloidosis [1]. **High-Yield NEET-PG Pearls:** * **Amyloid Type:** The specific amyloid in T2DM is **AIAPP** (Amylin). * **Staining:** Like all amyloid, it shows **Apple-green birefringence** under polarized light after **Congo Red staining**. * **Pathological Progression:** Islet amyloidosis is present in over 90% of T2DM patients at autopsy and correlates with the severity of the disease. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1119-1123.
Question 26: A 38-year-old woman undergoes a subtotal thyroidectomy. The biopsy specimen contains psammoma bodies and prominent papillae of epithelium with a fibrovascular core. The nuclear region of the cells shows groove formation, optical clearing, eosinophilic inclusions, and overlapping of nuclei. Which of the following is the most likely diagnosis?
- A. Follicular thyroid carcinoma
- B. Medullary thyroid carcinoma
- C. Papillary thyroid carcinoma (Correct Answer)
- D. Reidel's thyroiditis
Explanation: **Explanation:** The clinical and histopathological features described are classic for **Papillary Thyroid Carcinoma (PTC)**, the most common thyroid malignancy [1]. **1. Why the Correct Answer is Right:** The diagnosis is established by characteristic **nuclear features**, which are the "gold standard" for PTC [1]: * **Optically clear nuclei:** Also known as "Orphan Annie eye" nuclei [1], [2]. * **Nuclear grooves:** Longitudinal indentations of the nuclear membrane. * **Pseudoinclusions:** Eosinophilic cytoplasmic invaginations into the nucleus [1]. * **Overlapping nuclei:** Crowding due to lack of contact inhibition. * **Psammoma bodies:** Laminated calcifications (found in ~50% of cases) and **fibrovascular cores** within the papillae are highly suggestive architectural hallmarks [1]. **2. Why Incorrect Options are Wrong:** * **Follicular Thyroid Carcinoma:** Characterized by capsular or vascular invasion. It lacks the specific nuclear features of PTC and typically does not show psammoma bodies. * **Medullary Thyroid Carcinoma:** Derived from parafollicular C-cells [2]. It shows nests of cells in an **amyloid stroma** (Congo Red positive) and lacks papillae or Orphan Annie nuclei. * **Riedel’s Thyroiditis:** A rare inflammatory condition characterized by dense "woody" fibrous tissue replacing the thyroid parenchyma, often extending into adjacent neck structures. **3. High-Yield Clinical Pearls for NEET-PG:** * **Most common** thyroid cancer; associated with **radiation exposure** [1]. * **Prognosis:** Excellent (10-year survival >95%) [2]. * **Spread:** Primarily via **lymphatics** to cervical lymph nodes [2]. * **Genetic markers:** Most commonly associated with **BRAF mutations** (V600E) and **RET/PTC rearrangements** [1]. * **Psammoma bodies** in the thyroid are almost pathognomonic for PTC. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1098-1100. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 429-430.
Question 27: Which type of diabetes is associated with HLA?
- A. Type I diabetes (Correct Answer)
- B. Type II diabetes
- C. Malnutrition-related diabetes
- D. Gestational diabetes
Explanation: **Explanation:** **Type 1 Diabetes Mellitus (T1DM)** is primarily an autoimmune disease characterized by the destruction of pancreatic beta cells [1]. Its pathogenesis is strongly linked to genetic susceptibility, specifically within the **Major Histocompatibility Complex (MHC) class II** genes [1], [2]. Approximately 90-95% of Caucasians with T1DM carry **HLA-DR3 or HLA-DR4**, and the risk is highest in individuals who are heterozygous for both (DR3/DR4) [1]. These HLA alleles are responsible for defective self-antigen presentation, leading to the loss of self-tolerance in T-cells [1]. **Analysis of Incorrect Options:** * **Type 2 Diabetes:** This is characterized by insulin resistance and relative insulin deficiency. While it has a stronger overall genetic component (higher concordance in identical twins) than Type 1, it is **not** associated with HLA genes or autoimmune mechanisms [1]. * **Malnutrition-related Diabetes:** This is a secondary form of diabetes (often seen in tropical countries) related to pancreatic fibrosis or protein deficiency; it does not have an established HLA association. * **Gestational Diabetes:** This occurs due to hormonal changes during pregnancy (e.g., Human Placental Lactogen) causing insulin resistance. It is a transient metabolic state rather than an HLA-linked autoimmune condition. **High-Yield Clinical Pearls for NEET-PG:** * **Strongest Association:** HLA-DR3 and HLA-DR4 [1]. * **Protective Allele:** HLA-DQB1*0602 is known to provide protection against T1DM. * **Autoantibodies:** The presence of Islet Cell Antibodies (ICA), Anti-GAD65, and Anti-IA2 are diagnostic markers of the autoimmune process in T1DM. * **Insulitis:** The classic pathological finding in early T1DM is lymphocytic infiltration of the islets. [1] **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, p. 1113. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 177-178.
Question 28: Acidophil stem cell tumors present with all of the following features except?
- A. Hypogonadism
- B. Galactorrhea
- C. Acromegaly
- D. Thyrotoxicosis (Correct Answer)
Explanation: **Explanation:** **Acidophil Stem Cell Adenoma** is a rare, aggressive subtype of pituitary adenoma derived from the common precursor of somatotrophs and lactotrophs. Understanding its pathophysiology is key to identifying its clinical presentation. **Why Thyrotoxicosis is the correct answer:** Acidophil stem cell tumors involve the **acidophil lineage** (Growth Hormone and Prolactin). They do not involve thyrotrophs (which produce TSH). Therefore, these tumors do not cause secondary hyperthyroidism or thyrotoxicosis [1]. Thyrotoxicosis in pituitary pathology is typically associated with rare TSH-secreting adenomas (thyrotroph adenomas) [1]. **Analysis of other options:** * **Galactorrhea:** These tumors consistently produce **Prolactin**. Hyperprolactinemia is a hallmark feature, leading to galactorrhea in both males and females [1], [2]. * **Hypogonadism:** High levels of Prolactin inhibit the pulsatile release of GnRH from the hypothalamus, leading to decreased LH/FSH and subsequent hypogonadism (presenting as infertility or decreased libido) [2]. * **Acromegaly:** Although these tumors produce Growth Hormone (GH), they are characterized by "oncocytic" changes and inefficient hormone secretion [1]. While patients may have elevated GH levels, the clinical features of acromegaly are often **mild or subclinical** compared to pure somatotroph adenomas, but they are still a recognized feature [3]. **High-Yield NEET-PG Pearls:** 1. **Histology:** Characterized by **oncocytic change** (mitochondrial accumulation) and **fibrous bodies** (cytoplasmic inclusions). 2. **Staining:** They show immunoreactivity for both **GH and Prolactin**, but Prolactin effects usually dominate clinically [1]. 3. **Behavior:** These are more aggressive and invasive than standard prolactinomas and often show a poor response to dopamine agonists. 4. **Misconception:** Do not confuse these with "Mammosomatotroph adenomas," which are slow-growing and cause overt acromegaly [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, p. 1079. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1081-1082. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 417-418.
Question 29: Which of the following describes humoral hypercalcemia of malignancy (HHM)?
- A. The rise in calcium levels due to parathyroid hormone-related peptide (PTH-rP) (Correct Answer)
- B. Paraneoplastic calcitonin production
- C. Vitamin D hypervitaminosis
- D. Parafollicular C-cell proliferation of the thyroid gland
Explanation: **Explanation:** **Humoral Hypercalcemia of Malignancy (HHM)** is the most common cause of hypercalcemia in hospitalized patients [1]. It occurs when a tumor secretes systemic factors that circulate in the blood and cause bone resorption and renal calcium reabsorption, mimicking primary hyperparathyroidism [1]. 1. **Why Option A is Correct:** The primary mediator of HHM is **Parathyroid Hormone-related Peptide (PTH-rP)** [2]. PTH-rP shares structural homology with the N-terminal of native PTH, allowing it to bind to the same **PTH-1 receptor** [2]. This leads to increased osteoclastic activity and decreased renal calcium excretion. It is most commonly associated with **Squamous Cell Carcinomas** (lung, head, and neck), renal cell carcinoma, and breast cancer [2]. 2. **Why Other Options are Incorrect:** * **Option B:** Calcitonin is a hormone that *lowers* serum calcium levels [3]. While medullary thyroid carcinoma produces excess calcitonin, it rarely causes clinical hypocalcemia and never causes hypercalcemia. * **Option C:** Vitamin D hypervitaminosis can cause hypercalcemia, but this is usually due to exogenous intake or granulomatous diseases (like Sarcoidosis) where macrophages convert Vitamin D to its active form (1,25-dihydroxyvitamin D) [1]. This is distinct from the "humoral" mechanism of PTH-rP. * **Option D:** Parafollicular C-cell proliferation leads to Medullary Thyroid Carcinoma, which secretes calcitonin, not PTH-rP [3]. **High-Yield NEET-PG Pearls:** * **Lab Profile in HHM:** High Calcium, Low PTH (suppressed by high Ca²⁺), and High PTH-rP. * **Most common cancer associated:** Squamous cell carcinoma of the lung. * **Note:** HHM is different from "Local Osteolytic Hypercalcemia," which is caused by direct bone metastasis (e.g., Multiple Myeloma) [1]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Osteoarticular And Connective Tissue Disease, pp. 667-668. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 338-339. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Osteoarticular And Connective Tissue Disease, pp. 664-665.
Question 30: All of the following are histological features of follicular carcinoma, except?
- A. Capsular and vascular invasion
- B. Uniform cells forming repetitive follicular pattern
- C. Intranuclear grooves and nuclear pseudo-inclusions (Correct Answer)
- D. Huhle cell variant present
Explanation: **Explanation:** The diagnosis of **Follicular Thyroid Carcinoma (FTC)** relies entirely on architectural and invasive features rather than nuclear characteristics [1]. **1. Why Option C is the correct answer:** **Intranuclear grooves and nuclear pseudo-inclusions** are the hallmark diagnostic features of **Papillary Thyroid Carcinoma (PTC)**, not Follicular Carcinoma [4]. These nuclear changes (including "Orphan Annie eye" nuclei) are used to identify PTC even in the absence of papillary architecture (e.g., the follicular variant of PTC) [3]. **2. Analysis of Incorrect Options:** * **Option A (Capsular and vascular invasion):** These are the **pathognomonic** requirements for diagnosing FTC [2]. Unlike Follicular Adenoma, which is completely encapsulated, FTC must show penetration through the full thickness of the capsule or invasion into the vessels outside the capsule [1]. * **Option B (Uniform cells forming repetitive follicles):** FTC typically consists of fairly uniform cells arranged in small, micro-follicular patterns containing thick colloid [1]. This distinguishes it from the macro-follicular pattern often seen in benign goiters. * **Option D (Hürthle cell variant):** This is a recognized histological variant of FTC (also called Oncocytic type) characterized by cells with abundant, granular, eosinophilic cytoplasm due to an accumulation of mitochondria. **Clinical Pearls for NEET-PG:** * **FNA Limitation:** Fine Needle Aspiration (FNA) **cannot** distinguish between Follicular Adenoma and Follicular Carcinoma because it cannot assess capsular or vascular integrity [1]. * **Spread:** Unlike Papillary Carcinoma (which spreads via lymphatics), Follicular Carcinoma spreads primarily via the **hematogenous route** to the lungs and bones [5]. * **Molecular Marker:** FTC is frequently associated with **RAS mutations** or the **PAX8-PPARG** fusion gene. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1100-1101. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 430-431. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1099-1100. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, p. 1099. [5] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 429-430.
Practice by Chapter
Pituitary Gland Disorders
Practice Questions
Thyroid Gland Diseases
Practice Questions
Parathyroid Gland Pathology
Practice Questions
Adrenal Cortical Disorders
Practice Questions
Adrenal Medullary Disorders
Practice Questions
Pancreatic Endocrine Disorders
Practice Questions
Multiple Endocrine Neoplasia Syndromes
Practice Questions
Diffuse Neuroendocrine System
Practice Questions
Pineal Gland Pathology
Practice Questions
Laboratory Diagnosis of Endocrine Diseases
Practice Questions
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free